FNA
Price
$13.09
Change
-$0.00 (-0.00%)
Updated
Apr 17 closing price
Capitalization
998.19M
68 days until earnings call
VMTHF
Price
$0.25
Change
-$0.04 (-13.79%)
Updated
Apr 21 closing price
Capitalization
409.91M
Interact to see
Advertisement

FNA vs VMTHF

Header iconFNA vs VMTHF Comparison
Open Charts FNA vs VMTHFBanner chart's image
Paragon 28
Price$13.09
Change-$0.00 (-0.00%)
Volume$19.38M
Capitalization998.19M
VENUS MEDTECH HANGZHOU
Price$0.25
Change-$0.04 (-13.79%)
Volume$5K
Capitalization409.91M
FNA vs VMTHF Comparison Chart
Loading...
View a ticker or compare two or three
VS
FNA vs. VMTHF commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNA is a Hold and VMTHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (FNA: $13.09 vs. VMTHF: $0.25)
Brand notoriety: FNA and VMTHF are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: FNA: 173% vs. VMTHF: 17%
Market capitalization -- FNA: $998.19M vs. VMTHF: $409.91M
FNA [@Medical Specialties] is valued at $998.19M. VMTHF’s [@Medical Specialties] market capitalization is $409.91M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FNA’s FA Score shows that 0 FA rating(s) are green whileVMTHF’s FA Score has 1 green FA rating(s).

  • FNA’s FA Score: 0 green, 5 red.
  • VMTHF’s FA Score: 1 green, 4 red.
According to our system of comparison, both FNA and VMTHF are a bad buy in the long-term.

Price Growth

FNA (@Medical Specialties) experienced а 0.00% price change this week, while VMTHF (@Medical Specialties) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.11%. For the same industry, the average monthly price growth was +4.70%, and the average quarterly price growth was -0.43%.

Reported Earning Dates

FNA is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.11% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

FUNDAMENTALS
Fundamentals
FNA($998M) has a higher market cap than VMTHF($410M). VMTHF YTD gains are higher at: 2225.926 vs. FNA (26.718). FNA has higher annual earnings (EBITDA): -26.92M vs. VMTHF (-324.03M). VMTHF has more cash in the bank: 2.96B vs. FNA (75.6M). VMTHF has less debt than FNA: VMTHF (70.8M) vs FNA (110M). VMTHF has higher revenues than FNA: VMTHF (416M) vs FNA (216M).
FNAVMTHFFNA / VMTHF
Capitalization998M410M243%
EBITDA-26.92M-324.03M8%
Gain YTD26.7182225.9261%
P/E Ratio370.37N/A-
Revenue216M416M52%
Total Cash75.6M2.96B3%
Total Debt110M70.8M155%
TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VTEX6.220.08
+1.30%
VTEX
PYPL71.65N/A
N/A
PayPal Holdings
HYFM3.18N/A
N/A
Hydrofarm Holdings Group Inc.
RRBI55.38-0.40
-0.72%
Red River Bancshares
MDGL273.35-3.89
-1.40%
Madrigal Pharmaceuticals

FNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, FNA has been loosely correlated with TMCI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if FNA jumps, then TMCI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FNA
1D Price
Change %
FNA100%
N/A
TMCI - FNA
42%
Loosely correlated
-3.02%
NPCE - FNA
38%
Loosely correlated
N/A
GMED - FNA
35%
Loosely correlated
-1.15%
KIDS - FNA
33%
Poorly correlated
-3.20%
EXAS - FNA
32%
Poorly correlated
-0.72%
More

VMTHF and

Correlation & Price change

A.I.dvisor tells us that VMTHF and AVCRF have been poorly correlated (+23% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VMTHF and AVCRF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VMTHF
1D Price
Change %
VMTHF100%
N/A
AVCRF - VMTHF
23%
Poorly correlated
-5.02%
LUCD - VMTHF
4%
Poorly correlated
N/A
BJDX - VMTHF
2%
Poorly correlated
N/A
FNA - VMTHF
1%
Poorly correlated
N/A
MDXH - VMTHF
1%
Poorly correlated
-1.44%
More